bluetongu
viru
btv
first
emerg
european
union
eu
peak
case
eu
spent
million
euro
erad
monitor
program
cofinanc
member
state
number
case
report
across
eu
far
last
year
vaccin
proven
effect
tool
control
prevent
diseas
facilit
safe
trade
live
anim
mammalian
cell
commonli
use
substrat
product
viral
vaccin
cell
use
product
bluetongu
vaccin
compani
use
roller
bottl
convent
bioreactor
take
account
manufactur
cost
import
possibl
use
singleus
bioreactor
sub
technolog
altern
roller
bottl
convent
bioreactor
explor
advantag
like
yield
product
time
reduct
elimin
clean
steril
step
need
bioreactor
valid
process
etc
qualiti
antigen
product
studi
cell
line
use
due
good
yield
cell
cultur
minimum
essenti
medium
glasgow
supplement
serum
growth
cell
viru
product
conduct
roller
bottl
rb
bioreactor
biostat
bplu
sub
hyclon
cell
bioreactor
sub
cultiv
use
microcarri
densiti
crystal
violet
dye
nucleu
stain
method
use
estim
cell
densiti
dissolv
oxygen
ph
automat
adjust
addit
gase
air
btv
serotyp
strain
use
experi
strain
suppli
veterinari
agrochem
research
centr
varcodacerva
ukkel
belgium
cell
confluent
rb
bioreactor
sub
infect
ident
condit
constant
multipl
infect
moi
harvest
viru
done
cytopath
effect
cpe
viru
product
evalu
antigen
obtain
sub
inactiv
binari
ethylenimin
bei
adjuv
aluminum
hydroxid
saponin
efficaci
vaccin
test
lamb
forti
monthold
lamb
includ
studi
thirti
lamb
vaccin
revaccin
week
later
subcutan
rout
ten
lamb
left
unvaccin
control
fortyfour
day
revaccin
lamb
challeng
antibodi
respons
vaccin
lamb
evalu
vaccin
moment
challeng
seroneutr
test
see
tabl
viremia
presenc
btv
genom
blood
sampl
evalu
real
time
qrtpcr
blood
sampl
obtain
challeng
four
week
challeng
figur
show
result
viru
titer
sub
compar
obtain
rb
bioreactor
viru
titer
reach
bioreactor
compar
level
obtain
sub
preliminari
result
prove
use
sub
yield
obtain
roller
bottl
increas
two
time
determin
neutral
antibodi
na
titer
btv
serotyp
sampl
taken
vaccin
revaccin
done
mean
seroneutr
test
tabl
show
geometr
mean
na
titer
lamb
vaccin
challeng
group
viral
gemon
could
detect
rtpcr
day
challeng
wherea
unvaccin
challeng
lamb
viral
genom
detect
day
pi
result
obtain
use
sub
concern
cell
concentr
viru
titer
similar
reach
bioreactor
higher
roller
bottl
efficaci
result
lamb
confirm
qualiti
antigen
produc
sub
similar
antigen
produc
roller
bottl
convent
bioreactor
think
possibl
use
dispos
system
vaccin
product
order
reduc
product
cost
sub
altern
convent
product
method
reduc
facil
complex
reduct
cost
build
possibl
rapid
expans
capac
product
reduct
capit
equip
equip
valid
etc
avoid
clean
process
reduct
risk
crosscontamin
